144/A 0001628280-25-046836 0001653881 XXXXXXXX LIVE 0001724521 Arcus Biosciences, Inc. 001-38419 3928 POINT EDEN WAY Hayward CA 94545 510-694-6200 Robert C. Goeltz II Officer Common Merrill Lynch

555 California St Ste 1800 San Francisco CA 94104

5000 100000 106430976 10/28/2025 NYSE Common 12/15/2023 10/28/2025 Arcus Biosciences N 5000 12/15/2023 Equity Compensation Y Form 144 being modified to add in the 10b5-1 plan adoption date. 10b5-1 plan modified on 2/23/2024. 10/28/2025 03/07/2023 Robert Goeltz